General Information

Description

Developer of insulin products. The company offers SmartInsulin, a self regulating injectable formulation for treating diabetes.

Company Status (as of 07-Apr-2014)

The company was acquired by Merck & Company (NSYE:MRK) for $500 million on December 3, 2010. The company is no longer actively tracked by PitchBook.